A Placebo Controlled Trial on Add-on Modafinil on the Anti-psychotic Treatment Emergent Hyperglycemia and Hyperlipidemia

Modafinil is non stimulant drug which is marketed for mainly Narcolepsy and daytime drowsiness. The clinical experience and Summary of Product Characteristics (SPC) of the drug also mentions Anorexia as one of the side effects. Anorexia can have a direct impact on the carbohydrate and fat intake, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasuna, Pathapati Lakshmi, Vijay Sagar, Kommu John, Sudhakar, Thatikonda Padma, Rao, Gundugurthi Prasada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031584/
https://www.ncbi.nlm.nih.gov/pubmed/24860217
http://dx.doi.org/10.4103/0253-7176.130982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031584/
https://www.ncbi.nlm.nih.gov/pubmed/24860217
http://dx.doi.org/10.4103/0253-7176.130982

Ejemplares similares